請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99852完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 簡國龍 | zh_TW |
| dc.contributor.advisor | Kuo-Liong Chien | en |
| dc.contributor.author | 林宥芊 | zh_TW |
| dc.contributor.author | Yu-Chien Lin | en |
| dc.date.accessioned | 2025-09-19T16:05:41Z | - |
| dc.date.available | 2025-09-20 | - |
| dc.date.copyright | 2025-09-19 | - |
| dc.date.issued | 2025 | - |
| dc.date.submitted | 2025-07-09 | - |
| dc.identifier.citation | 1. Olvera Lopez E, Ballard BD, Jan A. Cardiovascular Disease. StatPearls. Treasure Island (FL): StatPearls Publishing
Copyright © 2025, StatPearls Publishing LLC.; 2025. 2. Lindstrom M, DeCleene N, Dorsey H, Fuster V, Johnson CO, LeGrand KE, Mensah GA, Razo C, Stark B, Varieur Turco J and others. Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021. J Am Coll Cardiol 2022;80(25):2372-2425. 3. Wilby ML. Physical Mobility Impairment and Risk for Cardiovascular Disease. Health Equity 2019;3(1):527-531. 4. Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, Li H, Chin YH, Kong G, Anand VV and others. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol 2024. 5. Zhao D. Epidemiological Features of Cardiovascular Disease in Asia. JACC Asia 2021;1(1):1-13. 6. Cao B, Bray F, Ilbawi A, Soerjomataram I. Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target. Lancet Glob Health 2018;6(12):e1288-e1296. 7. Chao TH, Lin TH, Cheng CI, Wu YW, Ueng KC, Wu YJ, Lin WW, Leu HB, Cheng HM, Huang CC and others. 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I. Acta Cardiol Sin 2024;40(5):479-543. 8. Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H and others. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol 2021;5:100149. 9. Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G and others. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation 2022;146(5):e18-e43. 10. Tubbs AS, Dollish HK, Fernandez F, Grandner MA. Chapter 1 - The basics of sleep physiology and behavior. In: Grandner MA, editor. Sleep and Health: Academic Press; 2019. p 3-10. 11. Buysse DJ. Sleep health: can we define it? Does it matter? Sleep 2014;37(1):9-17. 12. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-Reported and Measured Sleep Duration: How Similar Are They? Epidemiology 2008;19(6):838-845. 13. Markun LC, Sampat A. Clinician-Focused Overview and Developments in Polysomnography. Curr Sleep Med Rep 2020;6(4):309-321. 14. Cudney LE, Frey BN, McCabe RE, Green SM. Investigating the relationship between objective measures of sleep and self-report sleep quality in healthy adults: a review. J Clin Sleep Med 2022;18(3):927-936. 15. Li J, Vitiello MV, Gooneratne NS. Sleep in Normal Aging. Sleep Med Clin 2018;13(1):1-11. 16. Chaput JP, Dutil C, Sampasa-Kanyinga H. Sleeping hours: what is the ideal number and how does age impact this? Nat Sci Sleep 2018;10:421-430. 17. Kjorstad K, Vedaa O, Pallesen S, Saxvig IW, Hysing M, Sivertsen B. Circadian preference in young adults: Associations with sleep and mental health outcomes from a national survey of Norwegian university students. Chronobiol Int 2022;39(11):1465-1474. 18. Consensus Conference P, Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA and others. Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the Recommended Amount of Sleep for a Healthy Adult: Methodology and Discussion. J Clin Sleep Med 2015;11(8):931-52. 19. Kerkhof GA. Epidemiology of sleep and sleep disorders in The Netherlands. Sleep Med 2017;30:229-239. 20. Chattu VK, Manzar MD, Kumary S, Burman D, Spence DW, Pandi-Perumal SR. The Global Problem of Insufficient Sleep and Its Serious Public Health Implications. Healthcare (Basel) 2018;7(1). 21. Tao Z, Feng Y, Liu J, Tao L. Trends and disparities in sleep quality and duration in older adults in China from 2008 to 2018: A national observational study. Front Public Health 2023;11:998699. 22. Liu Y, Wheaton AG, Chapman DP, Cunningham TJ, Lu H, Croft JB. Prevalence of Healthy Sleep Duration among Adults--United States, 2014. MMWR Morb Mortal Wkly Rep 2016;65(6):137-41. 23. Chen Y, Kartsonaki C, Clarke R, Guo Y, Du H, Yu C, Yang L, Pei P, Stevens R, Burgess S and others. Sleep duration and risk of stroke and coronary heart disease: a 9-year community-based prospective study of 0.5 million Chinese adults. BMC Neurol 2023;23(1):327. 24. Svensson T, Saito E, Svensson AK, Melander O, Orho-Melander M, Mimura M, Rahman S, Sawada N, Koh WP, Shu XO and others. Association of Sleep Duration With All- and Major-Cause Mortality Among Adults in Japan, China, Singapore, and Korea. JAMA Netw Open 2021;4(9):e2122837. 25. Ikehara S, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, Inaba Y, Tamakoshi A. Association of sleep duration with mortality from cardiovascular disease and other causes for japanese men and women: The JACC study. Sleep 2009;32(3):295-301. 26. Svensson T, Inoue M, Saito E, Sawada N, Iso H, Mizoue T, Goto A, Yamaji T, Shimazu T, Iwasaki M and others. The Association Between Habitual Sleep Duration and Mortality According to Sex and Age: The Japan Public Health Center-based Prospective Study. J Epidemiol 2021;31(2):109-118. 27. Kwon S, Lee H, Lee JT, Shin MJ, Choi S, Oh H. Sleep duration and mortality in Korean adults: a population-based prospective cohort study. BMC Public Health 2020;20(1):1623. 28. Chien KL, Chen PC, Hsu HC, Su TC, Sung FC, Chen MF, Lee YT. Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort. Sleep 2010;33(2):177-84. 29. Liang YY, Ai S, Xue H, Chen Y, Zhou J, Shu X, Weng F, Zhou M, Ma H, Zhang J and others. Joint Associations of Device-Measured Sleep Duration and Efficiency With All-Cause and Cause-Specific Mortality: A Prospective Cohort Study of 90 398 UK Biobank Participants. J Gerontol A Biol Sci Med Sci 2023;78(9):1717-1724. 30. Zhao B, Meng Y, Jin X, Xi W, Ma Q, Yang J, Ma X, Yan B. Association of Objective and Self-Reported Sleep Duration With All-Cause and Cardiovascular Disease Mortality: A Community-Based Study. J Am Heart Assoc 2023;12(6):e027832. 31. Jin Q, Yang N, Dai J, Zhao Y, Zhang X, Yin J, Yan Y. Association of Sleep Duration With All-Cause and Cardiovascular Mortality: A Prospective Cohort Study. Front Public Health 2022;10:880276. 32. Xiao Q, Keadle SK, Hollenbeck AR, Matthews CE. Sleep duration and total and cause-specific mortality in a large US cohort: interrelationships with physical activity, sedentary behavior, and body mass index. Am J Epidemiol 2014;180(10):997-1006. 33. Ikehara S, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, Inaba Y, Tamakoshi A, Group JS. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009;32(3):295-301. 34. Chien KL, Su TC, Jeng JS, Hsu HC, Chang WT, Chen MF, Lee YT, Hu FB. Carotid artery intima-media thickness, carotid plaque and coronary heart disease and stroke in Chinese. PLoS One 2008;3(10):e3435. 35. Sands-Lincoln M, Loucks EB, Lu B, Carskadon MA, Sharkey K, Stefanick ML, Ockene J, Shah N, Hairston KG, Robinson JG and others. Sleep duration, insomnia, and coronary heart disease among postmenopausal women in the Women's Health Initiative. J Womens Health (Larchmt) 2013;22(6):477-86. 36. Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, van den Berg JF, Verschuren WM. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep 2011;34(11):1487-92. 37. Strand LB, Tsai MK, Gunnell D, Janszky I, Wen CP, Chang SS. Self-reported sleep duration and coronary heart disease mortality: A large cohort study of 400,000 Taiwanese adults. Int J Cardiol 2016;207:246-51. 38. Kawachi T, Wada K, Nakamura K, Tsuji M, Tamura T, Konishi K, Nagata C. Sleep Duration and the Risk of Mortality From Stroke in Japan: The Takayama Cohort Study. J Epidemiol 2016;26(3):123-30. 39. Tobaldini E, Fiorelli EM, Solbiati M, Costantino G, Nobili L, Montano N. Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence. Nat Rev Cardiol 2019;16(4):213-224. 40. Grandner MA, Sands-Lincoln MR, Pak VM, Garland SN. Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep 2013;5:93-107. 41. Matsubayashi H, Nagai M, Dote K, Turana Y, Siddique S, Chia YC, Chen CH, Cheng HM, Van Minh H, Verma N and others. Long sleep duration and cardiovascular disease: Associations with arterial stiffness and blood pressure variability. J Clin Hypertens (Greenwich) 2021;23(3):496-503. 42. Wang S, Li Z, Wang X, Guo S, Sun Y, Li G, Zhao C, Yuan W, Li M, Li X and others. Associations between sleep duration and cardiovascular diseases: A meta-review and meta-analysis of observational and Mendelian randomization studies. Front Cardiovasc Med 2022;9:930000. 43. Li C, Shang S. Relationship between Sleep and Hypertension: Findings from the NHANES (2007-2014). Int J Environ Res Public Health 2021;18(15). 44. Noga DA, Meth E, Pacheco AP, Tan X, Cedernaes J, van Egmond LT, Xue P, Benedict C. Habitual Short Sleep Duration, Diet, and Development of Type 2 Diabetes in Adults. JAMA Netw Open 2024;7(3):e241147. 45. Zhai L, Zhang H, Zhang D. Sleep Duration and Depression among Adults: A Meta-Analysis of Prospective Studies. Depress Anxiety 2015;32(9):664-70. 46. Covassin N, Singh P. Sleep Duration and Cardiovascular Disease Risk: Epidemiologic and Experimental Evidence. Sleep Med Clin 2016;11(1):81-9. 47. Amanda B, Meera CB, A M, S T. Biological pathways underlying the association between habitual long-sleep and elevated cardiovascular risk in adults. Sleep Medicine 2020. 48. Li Y, Sato Y, Yamaguchi N. Potential biochemical pathways for the relationship between sleep duration and mortality. Sleep Med 2013;14(1):98-104. 49. Sanchez Corredera C, Tadepalli PS, Scaccia J, Sibia AS, Mayrovitz HN. Implications of Long Sleep Duration on Cardiovascular Health: A Systematic Review. Cureus 2025;17(1):e77738. 50. Choi KM, Lee JS, Park HS, Baik SH, Choi DS, Kim SM. Relationship between sleep duration and the metabolic syndrome: Korean National Health and Nutrition Survey 2001. Int J Obes (Lond) 2008;32(7):1091-7. 51. Deschenes SS, Burns RJ, Graham E, Schmitz N. Depressive symptoms and sleep problems as risk factors for heart disease: a prospective community study. Epidemiol Psychiatr Sci 2019;29:e50. 52. Abe T, Aoki T, Yata S, Okada M. Sleep duration is significantly associated with carotid artery atherosclerosis incidence in a Japanese population. Atherosclerosis 2011;217(2):509-13. 53. Lee Y, Lin RS, Sung FC, Yang C, Chien K, Chen W, Su T, Hsu H, Huang Y. Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 2000;53(8):838-46. 54. Banauch D, Brummer W, Ebeling W, Metz H, Rindfrey H, Lang H, Leybold K, Rick W, Staudinger HJ. [A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]. Z Klin Chem Klin Biochem 1975;13(3):101-7. 55. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20(4):470-5. 56. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29(3):538-42. 57. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28(6):1379-88. 58. Chien KL, Sung FC, Hsu HC, Su TC, Lin RS, Lee YT. Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan Community Cardiovascular Study. Stroke 2002;33(1):39-44. 59. Chen PC, Chien KL, Hsu HC, Su TC, Chang CW, Sung FC, Lee YT. C-reactive protein and the metabolic syndrome correlate differently with carotid atherosclerosis between men and women in a Taiwanese community. Metabolism 2008;57(8):1023-8. 60. Hornung RW, and Reed LD. Estimation of Average Concentration in the Presence of Nondetectable Values. Applied Occupational and Environmental Hygiene 1990;5(1):46-51. 61. Su TC, Jeng JS, Chien KL, Sung FC, Hsu HC, Lee YT. Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke 2001;32(10):2265-71. 62. Chen PC, Jeng JS, Hsu HC, Su TC, Chien KL, Lee YT. Carotid Atherosclerosis Progression and Risk of Cardiovascular Events in a Community in Taiwan. Sci Rep 2016;6:25733. 63. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69(1):239-241. 64. Cox DR. Regression Models and Life-Tables. Journal of the Royal Statistical Society. Series B (Methodological) 1972;34(2):187-220. 65. Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. Journal of the American Statistical Association 1999;94(446):496-509. 66. Austin PC, Lee DS, Fine JP. Introduction to the Analysis of Survival Data in the Presence of Competing Risks. Circulation 2016;133(6):601-9. 67. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Springer; 2001. 68. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974;19(6):716-723. 69. Gregory AW, Veall MR. Formulating Wald Tests of Nonlinear Restrictions. Econometrica 1985;53(6):1465-1468. 70. Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package 'dagitty'. Int J Epidemiol 2016;45(6):1887-1894. 71. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51(6):1173-82. 72. Robins JM, Greenland S. Identifiability and exchangeability for direct and indirect effects. Epidemiology 1992;3(2):143-55. 73. VanderWeele T, Vansteelandt S. Conceptual issues concerning mediation, interventions and composition. Statistics and its Interface 2009;2:457-468. 74. VanderWeele TJ. A unification of mediation and interaction: a 4-way decomposition. Epidemiology 2014;25(5):749-61. 75. Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics 1983;39(2):499-503. 76. Full KM, Shi H, Lipworth L, Dauer LT, Mumma MT, Xiao Q. Sleep Trajectories and All-Cause Mortality Among Low-Income Adults. JAMA Netw Open 2025;8(2):e2462117. 77. Yin J, Jin X, Shan Z, Li S, Huang H, Li P, Peng X, Peng Z, Yu K, Bao W and others. Relationship of Sleep Duration With All-Cause Mortality and Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. J Am Heart Assoc 2017;6(9). 78. Wang C, Bangdiwala SI, Rangarajan S, Lear SA, AlHabib KF, Mohan V, Teo K, Poirier P, Tse LA, Liu Z and others. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries. Eur Heart J 2019;40(20):1620-1629. 79. Cai H, Shu XO, Xiang YB, Yang G, Li H, Ji BT, Gao J, Gao YT, Zheng W. Sleep duration and mortality: a prospective study of 113 138 middle-aged and elderly Chinese men and women. Sleep 2015;38(4):529-36. 80. Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006;29(8):1009-14. 81. Grandner M, Mullington JM, Hashmi SD, Redeker NS, Watson NF, Morgenthaler TI. Sleep Duration and Hypertension: Analysis of > 700,000 Adults by Age and Sex. J Clin Sleep Med 2018;14(6):1031-1039. 82. Fang J, Wheaton AG, Keenan NL, Greenlund KJ, Perry GS, Croft JB. Association of sleep duration and hypertension among US adults varies by age and sex. Am J Hypertens 2012;25(3):335-41. 83. Wang Y, Mei H, Jiang YR, Sun WQ, Song YJ, Liu SJ, Jiang F. Relationship between Duration of Sleep and Hypertension in Adults: A Meta-Analysis. J Clin Sleep Med 2015;11(9):1047-56. 84. He L, Yang N, Ping F, Xu L, Li W, Li Y, Zhang H. Long Sleep Duration is Associated with Increased High-Sensitivity C-Reactive Protein: A Nationwide Study on Chinese Population. Diabetes Metab Syndr Obes 2020;13:4423-4434. 85. Grandner MA, Buxton OM, Jackson N, Sands-Lincoln M, Pandey A, Jean-Louis G. Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 2013;36(5):769-779E. 86. Tanase DM, Gosav EM, Radu S, Ouatu A, Rezus C, Ciocoiu M, Costea CF, Floria M. Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? Int J Hypertens 2019;2019:3159283. 87. Huart J, Persu A, Lengele JP, Krzesinski JM, Jouret F, Stergiou GS. Pathophysiology of the Nondipping Blood Pressure Pattern. Hypertension 2023;80(4):719-729. 88. Lempiainen PA, Ylitalo A, Huikuri H, Kesaniemi YA, Ukkola OH. Non-dipping blood pressure pattern is associated with cardiovascular events in a 21-year follow-up study. J Hum Hypertens 2024;38(5):444-451. 89. Grandner MA, Drummond SP. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 2007;11(5):341-60. 90. Scott H, Lechat B, Guyett A, Reynolds AC, Lovato N, Naik G, Appleton S, Adams R, Escourrou P, Catcheside P and others. Sleep Irregularity Is Associated With Hypertension: Findings From Over 2 Million Nights With a Large Global Population Sample. Hypertension 2023;80(5):1117-1126. 91. Su Y, Li C, Long Y, He L, Ding N. Association Between Bedtime at Night and Systolic Blood Pressure in Adults in NHANES. Front Med (Lausanne) 2021;8:734791. 92. He Z, Chen Z, de Borst MH, Zhang Q, Snieder H, Thio CHL, On Behalf Of The International Consortium Of Blood P. Effects of Platelet Count on Blood Pressure: Evidence from Observational and Genetic Investigations. Genes (Basel) 2023;14(12). 93. Lip GY. Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited. Hypertension 2003;41(2):199-200. 94. Wang Z, Teng X. Causal mediation analysis of the role of platelet count in the association between depression and mortality in US adults. J Affect Disord 2025;389:119689. 95. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010;33(5):585-92. 96. Wang Z, Yang W, Li X, Qi X, Pan KY, Xu W. Association of Sleep Duration, Napping, and Sleep Patterns With Risk of Cardiovascular Diseases: A Nationwide Twin Study. J Am Heart Assoc 2022;11(15):e025969. 97. Amagai Y, Ishikawa S, Gotoh T, Kayaba K, Nakamura Y, Kajii E. Sleep duration and incidence of cardiovascular events in a Japanese population: the Jichi Medical School cohort study. J Epidemiol 2010;20(2):106-10. 98. Titova OE, Michaelsson K, Larsson SC. Sleep Duration and Stroke: Prospective Cohort Study and Mendelian Randomization Analysis. Stroke 2020;51(11):3279-3285. 99. Song Q, Liu X, Zhou W, Wang L, Zheng X, Wang X, Wu S. Long Sleep Duration and Risk of Ischemic Stroke and Hemorrhagic Stroke: the Kailuan Prospective Study. Sci Rep 2016;6:33664. 100. Pan A, De Silva DA, Yuan JM, Koh WP. Sleep duration and risk of stroke mortality among Chinese adults: Singapore Chinese health study. Stroke 2014;45(6):1620-5. 101. von Ruesten A, Weikert C, Fietze I, Boeing H. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS One 2012;7(1):e30972. 102. Chen JC, Brunner RL, Ren H, Wassertheil-Smoller S, Larson JC, Levine DW, Allison M, Naughton MJ, Stefanick ML. Sleep duration and risk of ischemic stroke in postmenopausal women. Stroke 2008;39(12):3185-92. 103. Lao XQ, Liu X, Deng HB, Chan TC, Ho KF, Wang F, Vermeulen R, Tam T, Wong MCS, Tse LA and others. Sleep Quality, Sleep Duration, and the Risk of Coronary Heart Disease: A Prospective Cohort Study With 60,586 Adults. J Clin Sleep Med 2018;14(1):109-117. 104. Yang L, Yang H, He M, Pan A, Li X, Min X, Zhang C, Xu C, Zhu X, Yuan J and others. Longer Sleep Duration and Midday Napping Are Associated with a Higher Risk of CHD Incidence in Middle-Aged and Older Chinese: the Dongfeng-Tongji Cohort Study. Sleep 2016;39(3):645-52. 105. Shankar A, Koh WP, Yuan JM, Lee HP, Yu MC. Sleep duration and coronary heart disease mortality among Chinese adults in Singapore: a population-based cohort study. Am J Epidemiol 2008;168(12):1367-73. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99852 | - |
| dc.description.abstract | 背景介紹：本研究探討不同睡眠時長和總死亡及心血管疾病死亡風險的關聯性，並進一步考慮動脈粥狀硬化標記物的中介角色，釐清異常睡眠時長是否會透過動脈粥狀硬化標記物間接影響死亡風險，以找出生物學的路徑。
方法：本研究為長期追蹤的世代研究，使用臺灣金山社區心血管疾病世代追蹤資料，排除資料不全者以及患有心血管疾病的受試者後，共納入3,305名受試者。透過結構式問卷蒐集人口學資料及習慣性睡眠時長，並抽取血液樣本檢測生化指標。睡眠時長分為三組，分別為短時間睡眠(≤6小時)、正常睡眠時間(7–8小時)和長時間睡眠(≥9小時)。利用Cox比例風險模型探討睡眠時長和全死因及心血管疾病死亡的關聯，並利用限制性立方曲線模型(Restricted Cubic Spline model)來判斷此關聯是否呈現非線性，更進一步利用因果中介分析來評估潛在的中介因子。 結果：經過中位數30.8年的追蹤期間下，調整潛在的干擾因子後，長時間睡眠相較於正常睡眠有顯著較高的全死因風險(調整後的HR: 1.17, 95% CI: 1.01, 1.35)，而短時間睡眠則未達顯著差異。長時間睡眠與心血管疾病死亡則未達顯著相關(調整後的HR: 1.18, 95% CI: 0.89, 1.56)。在年齡、性別、身體質量指數、高血壓和糖尿病分層分析皆未發現顯著交互作用。因果中介分析發現，收縮壓作為長時間睡眠和全死因之間的潛在中介因子，在基準測量和追蹤期間的間接效應分別為1.05 (95% CI: 1.02, 1.08)和1.03 (95% CI: 1.00, 1.06)。 結論：本研究發現較長的睡眠時間會增加全死因風險，此風險部分可由收縮壓所中介。 | zh_TW |
| dc.description.abstract | Introduction: The study investigated the association between sleep duration and the risks of all-cause and cardiovascular diseases death, and elucidated the mediating role of atherosclerotic markers in these associations to identify potential biological pathways.
Methods: We used data from the Chin-Shan Community Cardiovascular Cohort in Taiwan, a prospective study. After excluding individuals with incomplete data and those with cardiovascular diseases, 3,305 participants were included. Demographic data and habitual sleep duration were collected through structured questionnaires, and blood samples were obtained to assess biomarkers. Participants were classified into three sleep duration groups as short (≤6 hours), normal (7–8 hours), and long (≥9 hours). Cox proportional hazard models and restricted cubic splines assessed the associations and non-linear trends. Causal mediation analysis was performed to identify potential mediators. Results: During a median of 30.8 years of follow-up, after adjusting for potential confounding factors, long sleep duration was significantly associated with increased risks of all-cause mortality (adjusted hazard ratio: 1.17, 95% confidence interval: 1.01, 1.35), while short sleep duration showed no significant difference. Long sleep duration was not significantly associated with cardiovascular mortality (adjusted hazard ratio: 1.18, 95% confidence interval: 0.89, 1.56). Short sleep duration showed no significant association with either outcome. No significant interactions were found in subgroup analyses by age, sex, body mass index, hypertension, and diabetes. Systolic blood pressure was identified as a potential mediator between long sleep duration and all-cause mortality, with indirect effects of 1.05 (95% confidence interval: 1.02, 1.08) at baseline and 1.03 during follow-up (95% confidence interval: 1.00, 1.06). Conclusions: This study found that longer sleep duration increases the risk of all-cause mortality, which may be partially mediated by systolic blood pressure. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-19T16:05:41Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2025-09-19T16:05:41Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 口試委員會審定書 i
致謝 ii 中文摘要 iii English abstract iv Abbreviations vi Contents vii List of Figures x List of Tables ix Chapter 1 Introduction 1 1.1 Cardiovascular diseases 1 1.2 Sleep health 3 1.3 The association between sleep duration and the risk of all-cause and CVDs death 6 1.3.1 Short sleep duration and the risk of all-cause death 6 1.3.2 Long sleep duration and the risk of all-cause death 8 1.3.3 Sleep durations and the risk of CVDs death 9 1.3.4 Sex differences, geographic variations, and methodological differences 10 1.4 Biochemical mechanisms linking sleep duration to CVDs 12 1.5 Potential mediators underlying the relationship between long sleep duration and CVDs risk 14 1.6 Research gaps 15 1.7 Study hypotheses and aims 16 Chapter 2 Materials and Methods 18 2.1 Study design and participants 18 2.2 Exposure measurements 19 2.3 Atherosclerotic markers measurements 20 2.3.1 Venus blood sample 20 2.3.2 Lipid and apolipoprotein measurements 20 2.3.3 C-reactive protein measurement 21 2.3.4 Extracranial carotid artery ultrasonographic measurement 22 2.4 Endpoint ascertainment 23 2.5 Confounding factors 24 2.6 Statistical analyses 25 2.6.1 Descriptive part 25 2.6.2 Analytic part 26 2.6.3 Causal mediation analysis 28 2.6.4 Sensitivity analysis 30 2.6.5 Sample size and power calculation 30 Chapter 3 Results 32 3.1 Baseline characteristics of the current study 32 3.2 The association between habitual sleep durations and the risk of all-cause and CVDs death 35 3.3 Subgroup analyses according to age group, sex, BMI, hypertension, and diabetes 39 3.4 The mediation effects on the relationship between long sleep duration and the risk of all-cause death 40 3.5 Sensitivity analyses 44 3.5.1 The association between long sleep duration and all-cause and CVDs mortality based on Life’s Essential 8 44 3.5.2 Re-categorization and exclusion of extreme short sleep durations 45 Chapter 4 Discussion 47 4.1 Main findings 47 4.2 Comparisons with previous studies 48 4.2.1 The relationship between habitual sleep durations and the risks of all-cause and CVDs death 48 4.3 Potential biochemical mechanisms 50 4.3.1 SBP as a partial mediator in the long sleep duration-mortality relationship 50 4.3.2 DBP and platelet as a partial mediator in the long sleep duration-mortality relationship 54 4.4 Clinical implications 55 4.5 Strengths and limitations 56 4.5.1 Strengths 56 4.5.2 Limitations 56 4.6 Conclusions 58 Reference 59 | - |
| dc.language.iso | en | - |
| dc.subject | 全死因死亡 | zh_TW |
| dc.subject | 心血管疾病死亡 | zh_TW |
| dc.subject | 睡眠時長 | zh_TW |
| dc.subject | 收縮壓 | zh_TW |
| dc.subject | 因果中介分析 | zh_TW |
| dc.subject | cardiovascular diseases death | en |
| dc.subject | sleep duration | en |
| dc.subject | systolic blood pressure | en |
| dc.subject | all-cause death | en |
| dc.subject | causal mediation analysis | en |
| dc.title | 長時間睡眠與心血管疾病及全死因風險：動脈粥樣硬化標記物在臺灣社區型世代研究中的中介角色 | zh_TW |
| dc.title | Long Sleep Duration and The Risk of Cardiovascular Diseases and Total Death: The Mediating Role of Atherosclerotic Markers in a Taiwanese Community-Based Cohort | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 113-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 李文宗;曾翎威;王睿;白其卉 | zh_TW |
| dc.contributor.oralexamcommittee | Wen-Chung Li;Ling-Wei Chen;Jui Wang;Chyi-Huey Bai | en |
| dc.subject.keyword | 全死因死亡,心血管疾病死亡,睡眠時長,收縮壓,因果中介分析, | zh_TW |
| dc.subject.keyword | all-cause death,cardiovascular diseases death,sleep duration,systolic blood pressure,causal mediation analysis, | en |
| dc.relation.page | 114 | - |
| dc.identifier.doi | 10.6342/NTU202501599 | - |
| dc.rights.note | 未授權 | - |
| dc.date.accepted | 2025-07-09 | - |
| dc.contributor.author-college | 公共衛生學院 | - |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | - |
| dc.date.embargo-lift | N/A | - |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-113-2.pdf 未授權公開取用 | 1.56 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。